DocGo Inc.

Healthcare

NASDAQ:DCGO · NASDAQ Capital Market

Market Cap $55.93M Beta 1.00 P/E (TTM) -0.3

$0.52 -4.29%

-$0.02 today

52W Low $0.49High $1.78

Vol 1.06M · Avg 0.87M

EPS (TTM) -$1.90Medical - Care Facilities

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-69.02%

Period High

$1.73

Period Low

$0.52

Latest

$0.52

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Immix Biopharma, Inc.

NASDAQ:IMMX

$510.45M

Prelude Therapeutics Incorporated

NASDAQ:PRLD

$330.48M

Ovid Therapeutics Inc.

NASDAQ:OVID

$312.57M

MacroGenics, Inc.

NASDAQ:MGNX

$260.93M

Quipt Home Medical Corp.

QIPT

$162.30M

AVITA Medical, Inc.

NASDAQ:RCEL

$98.50M

Coya Therapeutics, Inc.

NASDAQ:COYA

$89.05M

Microbot Medical Inc.

NASDAQ:MBOT

$83.41M

Vivani Medical, Inc.

NASDAQ:VANI

$69.12M

InspireMD, Inc.

NSPR

$33.26M

What is the latest DCGO filing?

The latest filing shown is 4 dated May 14, 2026.

How many recent filings does DCGO have?

Intrinsic Alpha currently shows 20 recent filings for DCGO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.